4 minute read
Nov. 28, 2022
UCB7362: an Oral Plasmepsin X (PMX) Inhibitor to Treat Malaria
UCB7362
oral PMX inhibitor for malaria 50 mg QD/7 days estimated to be curative from guanidine-based focused lib. screen. and SBDD J. Med. Chem. UCB Biopharma, Braine-l’Alleud, BE